PL366316A1 - Hamowanie angiogenezy i wzrostu guza - Google Patents

Hamowanie angiogenezy i wzrostu guza

Info

Publication number
PL366316A1
PL366316A1 PL01366316A PL36631601A PL366316A1 PL 366316 A1 PL366316 A1 PL 366316A1 PL 01366316 A PL01366316 A PL 01366316A PL 36631601 A PL36631601 A PL 36631601A PL 366316 A1 PL366316 A1 PL 366316A1
Authority
PL
Poland
Prior art keywords
angiogenesis
inhibition
tumor growth
tumor
growth
Prior art date
Application number
PL01366316A
Other languages
English (en)
Other versions
PL205134B1 (pl
Inventor
Dale L. Boger
David A. Cheresh
Original Assignee
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Scripps Research Institute filed Critical The Scripps Research Institute
Publication of PL366316A1 publication Critical patent/PL366316A1/pl
Publication of PL205134B1 publication Critical patent/PL205134B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL366316A 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny PL205134B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27

Publications (2)

Publication Number Publication Date
PL366316A1 true PL366316A1 (pl) 2005-01-24
PL205134B1 PL205134B1 (pl) 2010-03-31

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
PL366316A PL205134B1 (pl) 2000-03-27 2001-03-27 Pochodne glicylolizyny, preparat farmaceutyczny i zastosowanie pochodnych glicylolizyny
PL01358272A PL358272A1 (pl) 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL01358272A PL358272A1 (pl) 2000-03-27 2001-03-27 Sposoby hamowania angiogenezy i wzrostu guza

Country Status (15)

Country Link
EP (2) EP1272173A4 (pl)
JP (2) JP2003528850A (pl)
KR (2) KR100767616B1 (pl)
CN (2) CN1229339C (pl)
AU (4) AU2001249499B2 (pl)
CA (3) CA2403630C (pl)
CZ (2) CZ20023510A3 (pl)
HU (2) HUP0301621A3 (pl)
MX (2) MXPA02009504A (pl)
NO (2) NO20024576L (pl)
PL (2) PL205134B1 (pl)
RU (2) RU2269339C2 (pl)
SK (2) SK14852002A3 (pl)
WO (2) WO2001072297A1 (pl)
ZA (2) ZA200208628B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
UA82561C2 (uk) 2003-10-23 2008-04-25 Оцука Фармасьютикалз Ко., Лтд. Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
RU2287341C1 (ru) * 2005-03-01 2006-11-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Ингибитор ангиогенеза, антиангиогенная фармацевтическая композиция на его основе и способ лечения злокачественных новообразований
SI2170279T1 (en) 2007-07-31 2018-04-30 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
RU2404794C2 (ru) * 2008-11-27 2010-11-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Вагинальные суппозитории для лечения рака шейки матки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
EP0968423A4 (en) * 1997-02-07 2002-10-30 Scripps Research Inst CONVERGENT SYNTHESIS OF A COMBINATORY LIBRARY
JP2002509881A (ja) * 1998-03-27 2002-04-02 ジェネンテク・インコーポレイテッド Ｃｄ１１／ｃｄ１８接着レセプター媒介疾患の治療用アンタゴニスト

Also Published As

Publication number Publication date
NO20024576L (no) 2002-11-20
AU2001249499B2 (en) 2005-04-21
PL358272A1 (pl) 2004-08-09
HUP0301621A2 (hu) 2003-09-29
NO328969B1 (no) 2010-06-28
KR20020084258A (ko) 2002-11-04
CA2659030A1 (en) 2001-10-04
EP1272173A4 (en) 2006-05-03
CA2403871A1 (en) 2001-10-04
CN1229339C (zh) 2005-11-30
HUP0301621A3 (en) 2009-06-29
KR100776185B1 (ko) 2007-11-16
NO20024576D0 (no) 2002-09-24
AU5101801A (en) 2001-10-08
CZ20023509A3 (cs) 2003-06-18
NO20024578L (no) 2002-11-20
SK14842002A3 (sk) 2003-04-01
CN1245967C (zh) 2006-03-22
AU2001251018B2 (en) 2005-12-01
ZA200208626B (en) 2004-02-16
CA2403871C (en) 2010-05-11
EP1272173A1 (en) 2003-01-08
AU4949901A (en) 2001-10-08
WO2001072297A1 (en) 2001-10-04
CA2403630C (en) 2009-05-26
NO20024578D0 (no) 2002-09-24
PL205134B1 (pl) 2010-03-31
ZA200208628B (en) 2004-02-12
JP2003528850A (ja) 2003-09-30
CN1429106A (zh) 2003-07-09
SK14852002A3 (sk) 2003-06-03
KR100767616B1 (ko) 2007-10-18
MXPA02009510A (es) 2003-05-21
HUP0301797A3 (en) 2010-09-28
EP1276713A1 (en) 2003-01-22
CA2403630A1 (en) 2001-10-04
JP2003528140A (ja) 2003-09-24
EP1276713A4 (en) 2006-05-03
RU2276133C2 (ru) 2006-05-10
CN1441777A (zh) 2003-09-10
CZ20023510A3 (cs) 2003-03-12
WO2001072699A1 (en) 2001-10-04
HUP0301797A2 (hu) 2003-09-29
MXPA02009504A (es) 2003-05-21
RU2269339C2 (ru) 2006-02-10
KR20020091156A (ko) 2002-12-05
RU2002128751A (ru) 2004-03-10

Similar Documents

Publication Publication Date Title
NO20024627D0 (no) Inhibering av cyklooksygenase-1-aktivitet
EE200900039A (et) KinasoliiniÁderivaadidÁangiogeneesiÁinhibiitoritenaÁjaÁvahehendid
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
DE60130735D1 (de) Verminderung des haarwuchses
EE05481B1 (et) Kinasoliini derivaadid kasvajate raviks
ID30590A (id) Celana sekali pakai jenis-celana pendek
EP1147107A4 (en) ANGIOGENESIS INHIBITORS
EP1196158A4 (en) INHIBITION OF ANGIOGENESIS THROUGH THE USE OF CURCUMIN AND CURCUMINOIDS
DE69822669D1 (de) Verminderung des haarwuchses
DE69934510D1 (de) Verminderung des haarwuchses
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
ID30187A (id) Dongkrak jenis pantagraf
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
NO20030978L (no) Behandling av urindysfunksjon
NO20024236D0 (no) Behandling av psoriasis
PL366316A1 (pl) Hamowanie angiogenezy i wzrostu guza
PT1272456E (pt) Inibidores de angiogenese de hidrazida e alcoxiamida
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20004109L (no) Stabilisering av formasjoner
AU2001268670A1 (en) Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
EP1354589A4 (en) ANGIOGENESIS INHIBITORS
NO20021234L (no) Anvendelse av tienopyrimidiner
FI20002526A7 (fi) Pyridatsinonijohdannaisten uusi käyttö
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
SE0000076D0 (sv) Ytbehandling av plaster

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110327